Nanobiosensors - Biosensors and Biosensor Kinetics - page 118

presently being used. Many more examples, and perhaps other categories, may be included,
that have recently or in the -too-distant past have appeared in the open literature. Neverthe-
less, with the classification presented here, the predominance of medical applications is obvi-
ous. With the current emphasis on the detection of biomarkers for different diseases such as
MI (myocardial infarction), and autoimmune diseases such as RA (rheumatoid arthritis) and
SLE (systemic lupus erythematosus), medical applications of biosensors will continue to
dominate the market, and the application of nanobiosensors in this area is not to be entirely
unexpected. Of course, the quantitative detection of glucose in blood to manage DM (diabe-
tes mellitus) will, as expected, continue to dominate the biosensor market, thanks to the
increasing obesity and minimum, if any, time spent by individuals on exercise.

Similarly, the papers that have been presented recently (in late 2009) at conferences may be
classified into similar categories for the detection of different analytes:

(a) Medical Applications

Biomedical applications Chomuchka et al. (2009)

Cancer Ma et al. (2009)

Glucose Zhu et al. (2009)

Cardiac markers Szymanski and Porter (2009)

(b) DNA

Unamplified DNA Verdold et al. (2009)

(c) Other Applications

pH sensing Lee et al. (2009)

SERS substrates Lin et al. (2009)

Luminescence enhancement Chowdhury et al. (2009)

Humidity sensing Jia et al. (2009)

DNA hybridization Wang et al. (2009)

Pathogen detection Nagaraja et al. (2009)

Biosensing applications Manther et al. (2009)

Enzyme kinetics Goluch et al. (2009)

Aptamer-target interactions Zhang et al. (2009)

Small molecule and protein detection Zhou et al. (2009)

Hydrogen peroxide Tian and Dale (2009)

Protein microarrays van Amerongen et al. (2009)

Mycotoxins Starodub et al. (2009)

Continued